Schechter Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Schechter Investment Advisors's PFE Position: Q1 2025 in Review
Schechter Investment Advisors increased its Pfizer (PFE) stake by 108% in Q1 2025, buying an estimated $238K and bringing the position to 17,456 shares worth $442K. The position accounts for 0.04% of the portfolio, ranked #397.
Schechter Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.76M in Q4 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Schechter Investment Advisors held 17,456 shares of Pfizer worth $442K as of Q1 2025.
- Schechter Investment Advisors bought 9,079 Pfizer shares in Q1 2025, an estimated $238K.
- Pfizer made up 0.04% of Schechter Investment Advisors's portfolio in Q1 2025, its #397 holding.
- Schechter Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
- Schechter Investment Advisors's Pfizer position peaked at $1.76M in Q4 2022.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.